VF
AUTL

Virtu Financial’s Autolus Therapeutics AUTL Stock Holding History

Virtu Financial’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,880
Closed -$32K – 1557
2023
Q3 		$32K Buy
+13,880
New +$39.5K ﹤0.01% 952
2022
Q1 		– Sell
-16,871
Closed -$88K – 1485
2021
Q4 		$88K Buy
+16,871
New +$101K 0.01% 1177
2021
Q3 		– Sell
-129,907
Closed -$863K – 1493
2021
Q2 		$863K Buy
+129,907
New +$806K 0.08% 251

Other funds holding AUTL

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu Financial's AUTL Position: Q4 2023 in Review

Virtu Financial sold out of Autolus Therapeutics (AUTL) in Q4 2023, closing a stake of 13,880 shares — an estimated $32K sold.

Virtu Financial first reported a position in AUTL in Q2 2021 and held it in 3 quarters. The position peaked at $863K in Q2 2021. 99 funds tracked by Wall St. Rank hold AUTL as of Q4 2023.

  • Virtu Financial reported no remaining Autolus Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 13,880 Autolus Therapeutics shares in Q4 2023, an estimated $32K.
  • Virtu Financial first reported a position in Autolus Therapeutics in Q2 2021 and held it in 3 quarters.
  • Virtu Financial's Autolus Therapeutics position peaked at $863K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.